🔴 Kailera Therapeutics is trading 4.4% down today on broader biotech sector weakness

Kailera Therapeutics is trading 4.4% down at $16.00 in after-hours trading, extending a recent multi-day slide amid broader biotech sector weakness.

• The move appears driven by a downturn in biotech ETFs like XBI, with no fresh, company-specific news or earnings reported for the company.
• Thin after-hours liquidity may be magnifying the downside move as selling pressure currently outweighs buyer interest.